Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Brachytherapy × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 21 Uterine Cervical Neoplasms 13 Endometrial Neoplasms 4 Esophageal Neoplasms 3 Vaginal Neoplasms 2 Rhabdomyosarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Uveal Melanoma 1 Recurrent Head and Neck Carcinoma 1 Recurrence 1 Radiation Injuries 1 Prostatic Diseases 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Locally Advanced Cervical Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Clear Cell Adenocarcinoma 1 Desmoplastic Small Round Cell Tumor 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡